1. Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling
   Najah Albadari et al, 2024, Frontiers in Pharmacology CrossRef
2. FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
   Jakub Szymczyk et al, 2021, Cancers CrossRef
3. Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers
   Khine S. Shan et al, 2024, International Journal of Molecular Sciences CrossRef
4. Targeting the Fibroblast Growth Factor Receptor (FGFR) Family in Lung Cancer
   Laura Pacini et al, 2021, Cells CrossRef
5. From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor
   Lewis D. Turner et al, 2022, Journal of Medicinal Chemistry CrossRef
6. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention
   Subhasmita Mahapatra et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
7. Steroid-induced fibroblast growth factors drive an epithelial-mesenchymal inflammatory axis in severe asthma
   Riccardo Guidi et al, 2022, Science Translational Medicine CrossRef
8. 2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology
   Richard J. Epstein et al, 2021, Journal of Oncology CrossRef
9. EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges
   Balakarthikeyan Janani et al, 2022, Vaccines CrossRef
10. FGFR inhibitors: Emerging treatments in advanced or metastatic cholangiocarcinoma
    Yasar Ahmed et al, 2021, Journal of Current Oncology CrossRef
11. Emerging genetic biomarkers in lung adenocarcinoma
    Jawad Barbar et al, 2022, SAGE Open Medicine CrossRef